The Motiva® Standard with Caroline Glicksman, MD, MSJ

Meet The Motiva® Standard, our unmatched safety profile.

We are pleased to share the preliminary results from our 3-year FDA IDE study. This study provides valuable insights into the safety and efficacy of Motiva® breast implants in large patient populations, which has been well documented in peer reviewed journals, and further demonstrated in independent patient registries. This milestone data comes from 3 million implants in the market for more than 12 years, with less than 1% device related complications.

Motiva® Implants are not yet commercially available in the US and are undergoing clinical investigation pursuant to US Food and Drug Administration (FDA) regulations for investigational medical devices.